Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New serum promises instant redness relief

NCT ID NCT07200492

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a facial serum can quickly soothe and repair skin redness. Thirty healthy Chinese women had redness induced on their faces and forearms, then received the serum on one side. The goal was to see if the serum reduces redness instantly and for up to 24 hours.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Eucerin Ultrasensitive Repair Intensive Source Serum
What this could lead to
If it works, this could point toward a quick-relief product for temporary skin redness.
What could go wrong
This is a small, early-stage study with only 30 participants, and redness was artificially induced, so results may not apply to real-world skin conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

32 people

The number who actually took part.

Started

Jan 2024

Finished

Jan 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Chinese female whose age range from 18 to 60 years old; 2. Be in general good health and good mental state; 3. Have no any broken,scars,birthmarks and other imperfections on the test area; 4. Redness/erythema≥grade 2 after modelling inducing and the score of redness must be increased after inducing; 5. Not currently be participating in any other study involving the test area(Face and Forearm); 6. Not have participated in any other study involving the test area in the past one month; 7. Be willing to read,understand and able to sign the Informed Consent Form and Photo Release From; 8. Be willing to comply with all study protocol requirements. Exclusion Criteria: 1. Intending to get pregnant, be pregnant, be lactating, be within 6 months of delivery or be unwilling to take necessary precautions to avoid a pregnancy; 2. Having used antihistamine drugs in the past 1 week or immunosuppressants in the past 1 month; 3. Taken anti-allergic drug/injections in the past 1 month; 4. Presently have allergies, allergic dermatitis or skin disease; 5. Have sensitivity or even allergy to topical products, ingredients or fragranced products; 6. Have history of allergies; 7. Have history of suffering from skin diseases (such as psoriasis, eczema, skin cancer, etc.); 8. Have used any anti-inflammatory treatment on the test area within 2 months prior to this study starting date; 9. Has a chronic medical condition that may interfere with testing (e.g., asthma, insulin-dependent diabetes, lupus, rheumatoid arthritis or other immune/auto-immune diseases); 10. Have used any scrubs or peeling product (regardless of method) or self-tanning products or oil control products in the past 3 days; 11. Have received cosmetic medical procedures on the face (such as injectable anti-wrinkle products, cosmetic surgery, tattoo removal, home light facial procedures or home use medical devices, etc.) in the past 1 month; 12. Have excessive sun exposure or ultraviolet light exposure in the past 1 month; 13. Have applied ortho-hydroxybenzoic acid, hydroquinone in the past 3 months; or used prescriptions (such as antibiotic, retinoids, alpha hydroxyl acid and steroid), oral contraceptives; 14. Avoid providing emergency contact; 15. Subjects that are not compliant with the selection criteria or not proper for participation as determined by Principal Investigator; 16. An employee of the cosmetic companies or Shanghai China-Norm Quality technical service Co., Ltd.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Redness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Erythema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shanghai China-norm Quality Technical Service Co., Ltd.

    Shanghai, Shanghai Municipality, 200072, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.